Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for ASPN and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for ASPN and 80,000+ other tickers.
See exactly how ASPN's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for ASPN and 80,000+ other tickers.
Aspen Aerogels, Inc. is a company dedicated to the development, manufacturing, and sale of advanced aerogel insulation products. These specialized solutions primarily serve the energy infrastructure and building materials sectors across a wide geographical area, encompassing the United States, Asia, Canada, Europe, and Latin America. Their extensive product portfolio includes PyroThin, designed as thermal barriers crucial for lithium-ion batteries in electric vehicles and various energy storage systems. For the energy infrastructure sector, Pyrogel XTE is offered to mitigate corrosion under…
BlackRock Inc. bought a new position in Aspen Aerogels, Inc. (NYSE: ASPN) during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 5,277,148 shares of the construction company's stock, valued at approximately $33,457,000. BlackRock Inc. owned 6.37% of Aspen Aerogels as of its most
Dimensional Fund Advisors LP lessened its position in shares of Aspen Aerogels, Inc. (NYSE: ASPN) by 37.3% during the undefined quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,256,480 shares of the construction company's stock after selling 747,483 shares during the quarter. Dimensional Fund
Aspen Aerogels delivered sequential revenue and EBITDA improvement, with Q2 revenues topping guidance and Q3 outlook signaling further recovery. Thermal Barrier sales rebounded sequentially, especially in Europe, but remain pressured by regulatory shifts and evolving battery technologies. ASPN's EBITDA break-even threshold lowered to $175 million in annual revenue, reflecting cost discipline and operational progress despite fire-related disruptions.
Consider the kinds of endeavors that capture our interest. My theory: They often relate to things we can see, understand and admire in day to day life. This is probably why more children aspire to be actors than, say, accountants, and why investors gravitate more to AI or fancy tech, than say, materials science.
Aspen Aerogels NYSE: ASPN said it expects a sharp sequential increase in revenue and adjusted EBITDA in the third quarter, supported by energy-industrial project deliveries, rising General Motors EV production and expanding European demand for its PyroThin thermal barriers.